← Back to Clinical Trials
RecruitingNCT06004440

Real World Registry for Use of the Ion Endoluminal System

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

ConditionLung Cancer
SponsorIntuitive Surgical
Study TypeOBSERVATIONAL
PhaseN/A
Enrollment3,000
SexALL
Min Age18 Years
Max AgeN/A
Start Date2023-09-21
Completion2029-08
Interventions
Ion Endoluminal System

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The primary objective of this study is to evaluate the performance of the Ion Endoluminal System with real-world use for pulmonary lesion localization or biopsy.

Eligibility Criteria

Inclusion Criteria: * Subject is 18 years or older at the time of the index procedure. * Subject is a candidate for an elective, planned lung lesion localization or biopsy procedure utilizing the Ion Endoluminal System. * Subject able to understand and adhere to study requirements and provide informed consent. Exclusion Criteria: * Subject is under the care of a Legally Authorized Representative (LAR) and is unable to provide informed consent on their own accord. * Subject is participating in an interventional research study or research study investigational agents with an unknown safety profile that would interfere with participation in this study. * Female subjects who are pregnant or nursing at the time of the index bronchoscopy procedure, as determined by standard site practices. * Subjects that are incarcerated or institutionalized under court order, or other vulnerable populations.

Related Trials